Wild Card
The "Golden Rule" for writing appeals.
What is payer policy comes first.
The NPI used to search for authorizations.
What is 1700887411.
The most important lab result when appealing Romiplostim.
What is the platelet count.
The name of the tab where all account notes can be seen.
What is three.
The ALL (Acute Lymphoblastic Leukemia) evidence block shows that this imaging is appropriate for work up if there are neurological symptoms.
What is a CT/MRI of the head with contrast.
The name of the targeted tumor-sequencing test available to MCK patients.
What is MSK-IMPACT.
Before clicking on the Authorizations or Claims in Availity, you should check this first.
What is the state.
The TWO most important lab results when appealing a FDG PET/CT denial.
What is blood glucose and creatinine.
The first tab to investigate in Epic when looking for an Authorization.
What is the Document Review tab.
The Colon Cancer Evidence Block shows that for recurrence and workup, this imaging is appropriate for work up if the cancer is resectable.
What is FDG-PET/CT.
The name of the tab in EPIC where transfusion records are found.
What is Flowsheets.
This will show you all authorization for MSKCC during a certain 90 day period for all payers.
What is the Authorization/Referral Dashboard.
The TWO most important lab results when appealing Pembrolizumab.
What is TSH and FT4.
The tab to find a weight for a past date of service.
What is the Chart Review tab.
The ALL (Acute Lymphoblastic Leukemia) Evidence Block shows that in Year 1, this lab should be monitored until normal.
What is LFTs.
The name of the tab in Epic that is a shortcut to the the active plan of treatment.
What is Chart Review- Oncology Treatment (Treatment Plan Manager).
You would choose this to search for one patient and one insurance authorization.
What is Authorization/Referral Inquiry.
The THREE most important lab results when appealing Bevacizumab.
What is WBC, RBC, and platelet count.
The tab containing notes from Case Management.
What is the Referral Tab.
According to the Non-Small Cell Lung Cancer Evidence Block, this is the initial treatment for dominant nodules when definitive local therapy is NOT possible.
What is palliative chemotherapy.
The HCPCS codes for the two most common biosimilars for J2506 (Pegfilgrastim).
What is Q5108 and Q5111.
This is found at the bottom of the web page that displays authorization results information.
What is correspondence regarding the authorization or denial.
The FOUR most important lab results when appealing Pegfilgrastim.
What is WBC, H/H, ANC, and platelet count.
For drug infusion appeals, you will find medical records in this type of encounter.
What is Infusion Clinic Encounter.
According to the Neuroblastoma Guidelines for intermediate patients, cycle 1 of system therapy contains these two chemotherapy drugs.
What is carboplatin and etoposide.